The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

16 articles for T Yokoyama


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of (phenoxy-2-hydroxypropyl)piperidines as a novel class of voltage-gated sodium channel 1.7 inhibitors.EBI
Daiichi Sankyo
Structural Insight into the Interactions between Death-Associated Protein Kinase 1 and Natural Flavonoids.EBI
University of Toyama
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.EBI
University of Toyama
Development of Benziodarone Analogues with Enhanced Potency for Selective Binding to Transthyretin in Human Plasma.EBI
University of Toyama
Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin.EBI
University of Toyama
Benziodarone and 6-hydroxybenziodarone are potent and selective inhibitors of transthyretin amyloidogenesis.EBI
University of Toyama
-Aryl Indoles as a Novel Class of Potent NaEBI
Daiichi Sankyo
Chlorinated Naringenin Analogues as Potential Inhibitors of Transthyretin Amyloidogenesis.EBI
University of Toyama
Repositioning of the Anthelmintic Drugs Bithionol and Triclabendazole as Transthyretin Amyloidogenesis Inhibitors.EBI
University of Toyama
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.EBI
University of Toyama
Transthyretin Amyloidogenesis Inhibitors: From Discovery to Current Developments.EBI
University of Toyama
Discovery of DS-1971a, a Potent, Selective NaEBI
Daiichi Sankyo
Crown Ethers as Transthyretin Amyloidogenesis Inhibitors.EBI
University of Toyama
Discovery of a new class of MTH1 inhibitor by X-ray crystallographic screening.EBI
University of Toyama
Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression.EBI
Kyoto Pharmaceutical University
Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors.EBI
Mochida Pharmaceutical